应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CBT 卡博特
休市中 12-05 16:00:00 EST
65.33
+1.23
+1.92%
盘后
65.33
+0.00
0.00%
19:35 EST
最高
65.59
最低
63.24
成交量
51.85万
今开
63.79
昨收
64.10
日振幅
3.66%
总市值
34.56亿
流通市值
34.29亿
总股本
5,290万
成交额
3,374万
换手率
0.99%
流通股本
5,249万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
港股异动 | 拨康视云-B(02592)盘中涨超4% 近一周累计涨幅逾八成 公司将加速CBT-009全球商业化潜力
智通财经 · 12-02
港股异动 | 拨康视云-B(02592)盘中涨超4% 近一周累计涨幅逾八成 公司将加速CBT-009全球商业化潜力
港股异动 | 拨康视云-B(02592)再涨超10% 核心产品CBT-009获得日本及欧洲专利
智通财经 · 11-28
港股异动 | 拨康视云-B(02592)再涨超10% 核心产品CBT-009获得日本及欧洲专利
拨康视云-B(02592)于日本及欧洲成功申请专利 将提升并加速CBT-009的全球商业化潜力
智通财经 · 11-27
拨康视云-B(02592)于日本及欧洲成功申请专利 将提升并加速CBT-009的全球商业化潜力
卡博特旗下炭黑产品,入选进博会2025年度十大展品!
炭黑产业网 · 11-24
卡博特旗下炭黑产品,入选进博会2025年度十大展品!
卡博特公司任命罗伯特·里斯特为投资者关系与企业规划副总裁
投资观察 · 11-20
卡博特公司任命罗伯特·里斯特为投资者关系与企业规划副总裁
卡博特第四季度调整后每股收益1.7美元,与IBES预期持平
投资观察 · 11-20
卡博特第四季度调整后每股收益1.7美元,与IBES预期持平
异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价
异动解读 · 11-04
异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价
异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价
异动解读 · 11-04
异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价
卡博特任命罗伯特·里斯特为投资关系及企业规划副总裁
美股速递 · 11-04
卡博特任命罗伯特·里斯特为投资关系及企业规划副总裁
卡博特2025财年第二财季实现净利润100.00百万美元,同比减少7.41%
市场透视 · 08-11
卡博特2025财年第二财季实现净利润100.00百万美元,同比减少7.41%
裕龙石化新项目获批,东岳集团技改项目公示,卡博特收购轮胎巨头炭黑厂……
中国化工信息周刊 · 08-08
裕龙石化新项目获批,东岳集团技改项目公示,卡博特收购轮胎巨头炭黑厂……
新股解读|核心产品CBT-001商业化还要等多久?拨康视云3年烧钱21亿再战港股
智通财经 · 06-16
新股解读|核心产品CBT-001商业化还要等多久?拨康视云3年烧钱21亿再战港股
港股异动 | 远大医药(00512)涨超3% 全球创新眼科药物CBT-001开展国际多中心III期临床试验
智通财经 · 06-09
港股异动 | 远大医药(00512)涨超3% 全球创新眼科药物CBT-001开展国际多中心III期临床试验
卡博特盘中异动 下午盘快速跳水5.16%
市场透视 · 03-04
卡博特盘中异动 下午盘快速跳水5.16%
卡博特盘中异动 下午盘急速上涨5.01%报89.12美元
市场透视 · 02-05
卡博特盘中异动 下午盘急速上涨5.01%报89.12美元
卡博特2025年第一季度每股盈利$1.76,超出$1.74预期,销售额$9.55亿未达$9.971亿预期
财报速递 · 02-04
卡博特2025年第一季度每股盈利$1.76,超出$1.74预期,销售额$9.55亿未达$9.971亿预期
卡博特跌1.87% 股价跌破100美元大关
市场透视 · 2024-12-18
卡博特跌1.87% 股价跌破100美元大关
卡博特2024财年实现净利润3.80亿美元,同比减少13.04%
市场透视 · 2024-11-10
卡博特2024财年实现净利润3.80亿美元,同比减少13.04%
卡博特盘中异动 早盘股价大涨5.82%
市场透视 · 2024-11-06
卡博特盘中异动 早盘股价大涨5.82%
抑郁症的电子丧钟,响了
虎嗅网 · 2024-11-06
抑郁症的电子丧钟,响了
加载更多
公司概况
公司名称:
卡博特
所属市场:
NYSE
上市日期:
--
主营业务:
Cabot Corporation业务初始于1882年,于1960年在特拉华州注册成立。该公司是一家全球特种化学品和性能材料公司,总部位于马萨诸塞州波士顿。公司主要产品为增强和特种碳、特种化合物、导电添加剂、碳纳米管、气相金属氧化物、喷墨着色剂和气凝胶。
发行价格:
--
{"stockData":{"symbol":"CBT","market":"US","secType":"STK","nameCN":"卡博特","latestPrice":65.33,"timestamp":1764968400000,"preClose":64.1,"halted":0,"volume":518540,"hourTrading":{"tag":"盘后","latestPrice":65.33,"preClose":65.33,"latestTime":"19:35 EST","volume":4745,"amount":309998.86,"timestamp":1764981323840},"delay":0,"floatShares":52489280,"shares":52898776,"eps":6.02,"marketStatus":"休市中","change":1.23,"latestTime":"12-05 16:00:00 EST","open":63.79,"high":65.585,"low":63.24,"amount":33743306.0272,"amplitude":0.036583,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.02,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":64.1,"dividendRate":0.02694,"preHourTrading":{"tag":"盘前","latestPrice":64.42,"preClose":64.1,"latestTime":"08:39 EST","volume":2,"amount":128.51999,"timestamp":1764941983391},"postHourTrading":{"tag":"盘后","latestPrice":65.33,"preClose":65.33,"latestTime":"19:35 EST","volume":4745,"amount":309998.86,"timestamp":1764981323840},"volumeRatio":1.0680588717025963,"impliedVol":0.1577,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/CBT","defaultTab":"news","newsList":[{"id":"2588088954","title":"港股异动 | 拨康视云-B(02592)盘中涨超4% 近一周累计涨幅逾八成 公司将加速CBT-009全球商业化潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2588088954","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588088954?lang=zh_cn&edition=full","pubTime":"2025-12-02 10:20","pubTimestamp":1764642042,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,拨康视云-B盘中涨超4%,近一周交易日累计涨幅逾八成。消息面上,近日,拨康视云-B发布公告,公司于美国特拉华州注册成立的全资附属公司ADS Therapeutics LLC已成功在日本及欧洲成功申请专利,该等专利涉及集团核心产品之一CBT-009。公司认为,该等专利申请的成功是CBT-009研发进程中的重要里程碑,将提升CBT-009的全球覆盖范围,并促进商业化进程。有关合作及许可安排预期将提升并加速CBT-009的全球商业化潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1376370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","02592","BK4090","BK1161"],"gpt_icon":0},{"id":"2586227105","title":"港股异动 | 拨康视云-B(02592)再涨超10% 核心产品CBT-009获得日本及欧洲专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2586227105","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586227105?lang=zh_cn&edition=full","pubTime":"2025-11-28 09:44","pubTimestamp":1764294298,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,拨康视云-B再涨超10%,本周累计涨幅接近70%。截至发稿,涨8.82%,报7.9港元,成交额621.89万港元。消息面上,拨康视云发布公告,美国全资附属ADS USA成功获日本专利局及欧洲专利局授出专利,涉及集团核心产品之一CBT-009。CBT-009是一种新型阿托品眼用制剂,用于治疗5至19岁儿童及青少年的青少年近视。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4090","CBT","02592","BK1161"],"gpt_icon":0},{"id":"2586242898","title":"拨康视云-B(02592)于日本及欧洲成功申请专利 将提升并加速CBT-009的全球商业化潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2586242898","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586242898?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:27","pubTimestamp":1764242834,"startTime":"0","endTime":"0","summary":"CBT-009作为集团的核心产品,是一种新型阿托品眼用制剂,用于治疗5至19岁儿童及青少年的青少年近视。集团亦已于2025年2月在中国开展幼年动物毒性研究,并正积极筹备CBT-009第3期临床试验的启动事宜。公司认为,该等专利申请的成功是CBT-009研发进程中的重要里程碑,将提升CBT-009的全球覆盖范围,并促进商业化进程。有关合作及许可安排预期将提升并加速CBT-009的全球商业化潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CBT","BK1161","02592","BK4090"],"gpt_icon":0},{"id":"2586341242","title":"卡博特旗下炭黑产品,入选进博会2025年度十大展品!","url":"https://stock-news.laohu8.com/highlight/detail?id=2586341242","media":"炭黑产业网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586341242?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:15","pubTimestamp":1763975749,"startTime":"0","endTime":"0","summary":"卡博特公司11月18日对外宣布,其自主研发的先进材料LITX 95F导电炭黑成功入选中国国际进口博览会“2025年度十大展品”榜单。作为全球规模领先的贸易与经济合作博览会,进博会设立“年度十大展品”奖项,旨在表彰那些对推动可持续、高质量经济发展具有突出贡献的卓越品牌及创新成果。据悉,第八届中国国际进口博览会吸引了155个国家、地区及国际组织参与,参展企业数量超过4100家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124202239a70e533e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124202239a70e533e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4090","CBT"],"gpt_icon":0},{"id":"1139955096","title":"卡博特公司任命罗伯特·里斯特为投资者关系与企业规划副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1139955096","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139955096?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:30","pubTimestamp":1763569853,"startTime":"0","endTime":"0","summary":"11月4日 - 卡博特公司宣布,罗伯特·里斯特被任命为投资者关系与企业规划副总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBT","BK4090"],"gpt_icon":0},{"id":"1128909337","title":"卡博特第四季度调整后每股收益1.7美元,与IBES预期持平","url":"https://stock-news.laohu8.com/highlight/detail?id=1128909337","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128909337?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:30","pubTimestamp":1763569817,"startTime":"0","endTime":"0","summary":"11月03日消息 - 卡博特第四季度净收入为4300万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","CBT"],"gpt_icon":0},{"id":"1136942380","title":"异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1136942380","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136942380?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:16","pubTimestamp":1762262199,"startTime":"0","endTime":"0","summary":"卡博特公司今日盘前股价大跌5.19%,引发市场关注。这一跌幅主要受到多家知名券商下调目标价的影响。这两家知名券商的目标价调整反映出分析师对卡博特公司未来表现的预期有所下降。卡博特公司是一家全球性的特种化学品和性能材料公司,其产品广泛应用于运输、基础设施、环境和消费等领域。券商下调目标价可能源于对全球经济增长放缓、原材料成本上升或行业竞争加剧等因素的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CBT"],"gpt_icon":0},{"id":"1160763336","title":"异动解读 | 卡博特股价盘前大跌5.19%,多家券商下调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1160763336","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160763336?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:16","pubTimestamp":1762262181,"startTime":"0","endTime":"0","summary":"卡博特股价今日盘前大跌5.19%,引发市场关注。消息面上,多家券商下调了卡博特的目标价,这可能是导致股价下跌的主要原因。据悉,杰富瑞将卡博特的目标价从92美元下调至79美元,降幅达14.1%。多家知名券商的目标价下调,反映出分析师对卡博特未来业绩表现的预期有所降低。在开盘前的交易中,投资者可能根据这些最新的分析师评级调整其持仓,从而引发了卡博特股价的大幅下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CBT"],"gpt_icon":0},{"id":"1170822253","title":"卡博特任命罗伯特·里斯特为投资关系及企业规划副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1170822253","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170822253?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:31","pubTimestamp":1762205477,"startTime":"0","endTime":"0","summary":"卡博特任命罗伯特·里斯特为投资关系及企业规划副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","CBT"],"gpt_icon":0},{"id":"2558681221","title":"卡博特2025财年第二财季实现净利润100.00百万美元,同比减少7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681221","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681221?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:00","pubTimestamp":1754841633,"startTime":"0","endTime":"0","summary":"8月11日,卡博特公布财报,公告显示公司2025财年第二财季净利润为100.00百万美元,同比减少7.41%;其中营业收入为9.23亿美元,同比减少9.15%,每股基本收益为1.87美元。从资产负债表来看,卡博特总负债21.54亿美元,其中短期债务1.10亿美元,资产负债比为1.79,流动比率为2.13。机构评级:截至2025年8月11日,当前有5家机构对卡博特目标价做出预测,其中目标均价为83.80美元,其中最低目标价为75.00美元,最高目标价为92.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000101a6de06aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000101a6de06aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBT"],"gpt_icon":0},{"id":"2557514127","title":"裕龙石化新项目获批,东岳集团技改项目公示,卡博特收购轮胎巨头炭黑厂……","url":"https://stock-news.laohu8.com/highlight/detail?id=2557514127","media":"中国化工信息周刊","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557514127?lang=zh_cn&edition=full","pubTime":"2025-08-08 12:16","pubTimestamp":1754626571,"startTime":"0","endTime":"0","summary":"热点新闻2025年8月8日01国内要闻裕龙石化新项目获批近日,山东裕龙石化有限公司下游及延伸产业链两个项目用海申请正式受理。02国际要闻卡博特收购轮胎巨头炭黑厂8月5日,普利司通株式会社对外宣布,已和卡博特公司达成协议,将其旗下全资子公司墨西哥炭黑制造有限公司予以出售。据悉,卡博特将以 7000万美元的价格收购 MXCB,预计将在未来3至6个月内完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808122017a6da2353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808122017a6da2353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBT","BK4090"],"gpt_icon":0},{"id":"2543537676","title":"新股解读|核心产品CBT-001商业化还要等多久?拨康视云3年烧钱21亿再战港股","url":"https://stock-news.laohu8.com/highlight/detail?id=2543537676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543537676?lang=zh_cn&edition=full","pubTime":"2025-06-16 18:13","pubTimestamp":1750068781,"startTime":"0","endTime":"0","summary":"据招股书,拨康视云一般及行政开支由2023年的0.11亿美元减少约180万美元或15.9%至2024年的约950万美元。CBT-001截至最后实际可行日期,并无临时数据可供分析。弗若斯特沙利文报告显示,CBT-001对应的全球治疗翼状胬肉药物的市场规模预计将于2027年达到273.4百万美元及于2032年达到2,529.4百万美元,复合年增长率为56.0%。然而,作为距离商业化最近的产品CBT-001,拨康视云已将部分权益让渡给远大医药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1305794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","YANG","BK4090","02592","CBT","HSCEI","BK4614"],"gpt_icon":1},{"id":"2542875798","title":"港股异动 | 远大医药(00512)涨超3% 全球创新眼科药物CBT-001开展国际多中心III期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2542875798","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542875798?lang=zh_cn&edition=full","pubTime":"2025-06-09 10:34","pubTimestamp":1749436457,"startTime":"0","endTime":"0","summary":"消息面上,远大医药发布公告,集团用于治疗翼状胬肉的全球创新眼科药物CBT-001开展的国际多中心III期临床试验,近日完成了全球中心全部患者入组。该研究是一项随机、双盲、安慰剂平行对照的III期临床试验,拟入组660例12周岁及以上的翼状胬肉伴结膜充血患者,旨在评估CBT-001滴眼液在减少结膜充血和预防翼状胬肉进展方面的安全性和有效性。中国加入CBT-001的国际多中心III期临床试验后,已于2024年3月实现中国III期临床研究首例患者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","03347","BK1141","00512","BK1191","III","BK1576","BK4090","CBT","BK1583"],"gpt_icon":0},{"id":"2516639606","title":"卡博特盘中异动 下午盘快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516639606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516639606?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:24","pubTimestamp":1741033499,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时24分,卡博特股票出现异动,股价急速跳水5.16%。截至发稿,该股报81.56美元/股,成交量20.8442万股,换手率0.38%,振幅5.24%。机构评级方面,在所有5家参与评级的机构中,40%的券商给予买入建议,40%的券商给予持有建议,20%的券商给予卖出建议。卡博特股票所在的化学制品行业中,整体跌幅为0.26%。卡博特公司简介:卡博特公司生产和销售各种化学品、材料和化学制品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042459abe69504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042459abe69504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4090","CBT"],"gpt_icon":0},{"id":"2509849523","title":"卡博特盘中异动 下午盘急速上涨5.01%报89.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509849523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509849523?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:54","pubTimestamp":1738698897,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时54分,卡博特股票出现波动,股价大幅上涨5.01%。截至发稿,该股报89.12美元/股,成交量44.7142万股,换手率0.82%,振幅5.61%。机构评级方面,在所有5家参与评级的机构中,40%的券商给予买入建议,40%的券商给予持有建议,20%的券商给予卖出建议。卡博特股票所在的化学制品行业中,整体涨幅为1.69%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020503545796180984&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020503545796180984&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBT","BK4090"],"gpt_icon":0},{"id":"1172882719","title":"卡博特2025年第一季度每股盈利$1.76,超出$1.74预期,销售额$9.55亿未达$9.971亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1172882719","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172882719?lang=zh_cn&edition=full","pubTime":"2025-02-04 05:40","pubTimestamp":1738618816,"startTime":"0","endTime":"0","summary":"卡博特报告季度每股收益为1.76美元,超出分析师一致预期的1.74美元,增幅为1.15%。公司季度销售额为9.55亿美元,未达到分析师一致预期的9.971亿美元,差距为4.22%。与上年同期的9.58亿美元销售额相比,下降了0.31%。以上内容来自Benzinga Earnings专栏,原文如下:Cabot reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.74 by 1.15 percent. This is a 12.82 percent increase over earnings of $1.56 per share from the same period last year. The company reported quarterly sales of $955.00 million which missed the analyst consensus estimate of $997.10 million by 4.22 per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卡博特2025年第一季度每股盈利$1.76,超出$1.74预期,销售额$9.55亿未达$9.971亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBT"],"gpt_icon":0},{"id":"2492997934","title":"卡博特跌1.87% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2492997934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492997934?lang=zh_cn&edition=full","pubTime":"2024-12-18 04:02","pubTimestamp":1734465764,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日04时02分,卡博特股票出现异动,股价急速跳水1.87%。截至发稿,该股报100.00美元/股,成交量13.0983万股,换手率0.24%,振幅1.71%。机构评级方面,在所有5家参与评级的机构中,40%的券商给予买入建议,40%的券商给予持有建议,20%的券商给予卖出建议。卡博特股票所在的化学制品行业中,整体涨幅为0.06%。卡博特公司简介:卡博特公司生产和销售各种化学品、材料和化学制品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218040245a1f699a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218040245a1f699a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBT","BK4090"],"gpt_icon":0},{"id":"2482427927","title":"卡博特2024财年实现净利润3.80亿美元,同比减少13.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482427927?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168165,"startTime":"0","endTime":"0","summary":"11月10日,卡博特公布财报,公告显示公司2024财年净利润为3.80亿美元,同比减少13.04%;其中营业收入为39.94亿美元,同比增加1.60%,每股基本收益为--。从资产负债表来看,卡博特总负债21.46亿美元,其中短期债务53.00百万美元,资产负债比为1.75,流动比率为2.08。机构评级:截至2024年11月10日,当前有5家机构对卡博特目标价做出预测,其中目标均价为116.60美元,其中最低目标价为105.00美元,最高目标价为127.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000317abb10131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000317abb10131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBT"],"gpt_icon":0},{"id":"2481856989","title":"卡博特盘中异动 早盘股价大涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481856989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481856989?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:38","pubTimestamp":1730903931,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时38分,卡博特股票出现波动,股价急速拉升5.82%。截至发稿,该股报115.20美元/股,成交量3.5638万股,换手率0.07%,振幅1.78%。卡博特股票所在的化学制品行业中,整体涨幅为0.40%。其相关个股中,Avient Corporation、Orion S.A.、英诺斯派材料涨幅较大,Gevo, Inc.、Crown Electrokinetics Corp.、中北能较为活跃,换手率分别为1.07%、0.55%、0.39%,振幅较大的相关个股有哈德森科技、Gevo, Inc.、Avient Corporation,振幅分别为8.43%、5.96%、5.51%。卡博特公司简介:Cabot Corp 生产和销售各种化学品、材料和化学制品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622385295bddd86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622385295bddd86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4090","CBT"],"gpt_icon":0},{"id":"2481047665","title":"抑郁症的电子丧钟,响了","url":"https://stock-news.laohu8.com/highlight/detail?id=2481047665","media":"虎嗅网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481047665?lang=zh_cn&edition=full","pubTime":"2024-11-06 07:12","pubTimestamp":1730848336,"startTime":"0","endTime":"0","summary":"“原来抑郁症会死人。”AI颠覆心理咨询,来势凶猛抑郁症、焦虑症、PUA、NPD,回避型依恋人格等曾经生僻的词汇,在心理压力越来越大的今天,越来越为大众所熟知了。号称世界第一的心理个评估工具“Limbic Access”,已经为全球超26万人提供了服务。经过短短3年的发展,“小天”的用户数量已经超过了10万。某全球知名社交平台引入的AI,通过语言预测精神分裂等精神疾病发作的准确率也达到83%。前述业内人士表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8eHT7BAImoT","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["BK4090","LU0128525689.USD","BK4592","IE00BJTD4N35.SGD","IE00BSNM7G36.USD","LU0234570918.USD","IE0034235303.USD","LU0106261372.USD","LU0170899867.USD","BK4581","BK4585","BK4538","LU0056508442.USD","LU0187121727.USD","LU0061475181.USD","BK4574","IE00BK4W5M84.HKD","IE00BKVL7J92.USD","BK4576","LU0096364046.USD","LU0127658192.USD","BK4077","LU0052756011.USD","LU0130517989.USD","IE0004091025.USD","CBT","LU0128525929.USD","LU0158827948.USD","LU0048573561.USD","BK4566","LU0130102774.USD","LU0006306889.USD","LU0109391861.USD","LU0154236417.USD","LU0029864427.USD","LU0215105999.USD","BK4573","LU0097036916.USD","IE00BKPKM429.USD","LU0080751232.USD","LU0061474705.USD","BK4579","IE0034235188.USD","BK4534","IE00BJTD4V19.USD","LU0130518102.USD","IE00BWXC8680.SGD","BK4533","IE00BK4W5L77.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.cabotcorp.com","stockEarnings":[{"period":"1week","weight":0.0441},{"period":"1month","weight":0.0804},{"period":"3month","weight":-0.194},{"period":"6month","weight":-0.1296},{"period":"1year","weight":-0.3698},{"period":"ytd","weight":-0.2845}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabot Corporation业务初始于1882年,于1960年在特拉华州注册成立。该公司是一家全球特种化学品和性能材料公司,总部位于马萨诸塞州波士顿。公司主要产品为增强和特种碳、特种化合物、导电添加剂、碳纳米管、气相金属氧化物、喷墨着色剂和气凝胶。","yearOnYearQuotes":[{"month":1,"riseRate":0.422222,"avgChangeRate":0.010738},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03031},{"month":3,"riseRate":0.622222,"avgChangeRate":0.019841},{"month":4,"riseRate":0.543478,"avgChangeRate":0.01928},{"month":5,"riseRate":0.434783,"avgChangeRate":0.001185},{"month":6,"riseRate":0.456522,"avgChangeRate":-0.000413},{"month":7,"riseRate":0.5,"avgChangeRate":0.019114},{"month":8,"riseRate":0.456522,"avgChangeRate":0.000293},{"month":9,"riseRate":0.478261,"avgChangeRate":-0.000003},{"month":10,"riseRate":0.456522,"avgChangeRate":-0.01138},{"month":11,"riseRate":0.673913,"avgChangeRate":0.018365},{"month":12,"riseRate":0.608696,"avgChangeRate":0.00922}],"exchange":"NYSE","name":"卡博特","nameEN":"Cabot"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卡博特(CBT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卡博特(CBT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卡博特,CBT,卡博特股票,卡博特股票老虎,卡博特股票老虎国际,卡博特行情,卡博特股票行情,卡博特股价,卡博特股市,卡博特股票价格,卡博特股票交易,卡博特股票购买,卡博特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卡博特(CBT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卡博特(CBT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}